Dynagen, Inc.

CPR

comprehensive proficiency reagents and kits for biochemical/biological markers, therapeutic drugs, and drugs of abuse, for clinical laboratory analysis;

DYNAVAX

human or animal diagnostic and therapeutic vaccines for viral and bacterial infection/disease;

EMPHYDYN

reagents and diagnostic kits for the detection of elastin peptides as a marker of emphysematous changes in lung tissue;

EMPHYDYN

reagents and diagnostic kits comprised primarily of reagents for the detection of elastin peptides as a marker of emphysematous changes in lung tissue;

EMPHYDYN

reagents and diagnostic kits comprised primarily of reagents for the detection of elastin peptides as a marker of emphysematous changes in lung tissue;

MYCOAKT

diagnostic reagents and test kits for detection of mycobacterial species in culture isolates for medical laboratory research;

MYCODYN

biochemical reagents and assays for the detection of mycobacterial infection and /or disease and for detection of compliance with therapies for mycobacterial infection and/or disease for clinical medical laboratory use;

MYCODYN

pharmaceutical preparations for treating mycobacterial infections and/or disease;

MYCODYN URITEC

biological reagents and test kits comprised essentially of reagent-coated test strips or human urines as controls, for testing urine samples, and in particular determining therapy compliance in connection with treatments relating to mycobacterial infection and/or disease for clinical or medical laboratory use;

MYCOWELL

microtiter plate assay and assay/kit components; namely, antigens, antibodies, controls, buffers, and detection reagents for clinical medical use;

NICAID

pharmaceutical preparations useful for immediate and temporary relief of tobacco withdrawal symptoms, and in particular nicotine craving;

NICEASE

pharmaceutical preparations useful as a temporary relief of tobacco withdrawal symptoms;

NICERASE

pharmaceutical preparation for the treatment of smoking;nic-erase; nicotine erase;

NICERASE

pharmaceutical preparations useful as an aid to smoking cessation, and in particular for the relief of nicotine withdrawal symptoms;NICOTINE ERASE;

NITROTAB

PHARMACEUTICAL TABLETS CONTAINING NITROGLYCERINE FOR THE TREATMENT OF ANGINA OR HEART DISORDERS;NITRO TAB;

ONCODYN

reagents and kits comprised primarily plates, slides, membranes, detection reagents, controls, buffers, antibodies and antigens for the diagnosis of cancer and drugs for the treatment of cancer;

ORTHODYN

biocompatible polymers for orthopedic bone repair, orthopedic prosthesis fixation and orthopedic drug delivery;

ORTHODYN

biocompatible polymers for orthopedic drug delivery;

PARAGEN

brochemical reagents and assays for detection of parasitic infection and/or diseases for medical diagnostic use;

PARAGEN

pharmaceutical preparation for treating parasitic infections and/or disease;

PCMS

pharmaceutical preparations; namely, formulations used as carriers during parenteral sustained delivery of medications;

PROCHECK

kits for use in drug abuse testing comprised of blind performance specimens, instructions, chain of custody certificates and laboratory performance evaluation forms;PRO-CHECK;

SERAMATE

semisynthitic serum matrix for use as controls and calibrators in therapeutic drug monitoring, substance abuse testing, and emergency room toxicology;

SLEEPER

delayed release preparation sold as a component of a full line of pharmaceuticals for human and veterinary use;

SLEEPER

vaccines;

SLEEPER

vaccines;

SLEEPER DOSE

delayed release preparation sold as a component of a full line of pharmaceuticals for human and veterinary use;DOSE;

SLUDGE BUSTER

municipal and industrial waste treatment units;SLUDGE;

SPT

biochemical reagents and assays for detection of mycobacterial infection for clinical medical laboratory use;

SPT

biochemical reagents and assays for detection of mycobacterial infection;

TWSI

publications; namely, index for standardizing the severity of the tobacco withdrawal syndrome;

URIMATE

semisynthetic urine matrix for use as controls and calibrators in therapeutic drug monitoring, substance abuse testing, and emergency room toxicology;

URITEC

biological reagents and test kits comprised essentially of reagent-coated test strips or human urines as controls, for testing urine samples, and in particular determining therapy compliance in connection with treatments relating to mycobacterial infection and/or disease;

ZOTRIM

pharmaceutical for urinary tract infections;

ZOTRIM

Pharmaceutical for the treatment of urinary tract infections;